Oropouche Virus: An Emerging Orthobunyavirus
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Oropouche virus (OROV) outbreak in 2024 has escalated significantly, with over 9852 cases confirmed. This highlights urgent needs for OROV vaccines and treatments due to sustained transmission and severe outcomes.
Area Of Science
- * Arbovirology
- * Public Health
- * Infectious Diseases
Background
- * Oropouche virus (OROV) has been a persistent public health issue in Central and South America since the 1960s.
- * The Pan American Health Organization/World Health Organization issued an alert on February 2, 2024, escalating to high by August 3, 2024, due to rising infections.
- * The 2024 outbreak is notable for sustained transmission in previously non-endemic Brazilian regions and local transmission in Cuba.
Purpose Of The Study
- * To provide a concise overview of Oropouche virus (OROV), a neglected orthobunyavirus.
- * To highlight the significance of the 2024 outbreak as a turning point in OROV epidemiology.
- * To underscore critical knowledge gaps in OROV pathogenesis and the urgent need for medical countermeasures.
Main Methods
- * This is a review article, synthesizing existing knowledge on OROV.
- * Data presented includes epidemiological alerts and case confirmations up to August 2024.
- * Focuses on the characteristics of the 2024 outbreak, including geographical spread and clinical observations.
Main Results
- * As of August 2024, 9852 OROV cases have been confirmed.
- * The outbreak involves sustained transmission in non-endemic areas of Brazil and local transmission in Cuba.
- * Severe outcomes include two fatalities and several cases of vertical transmission.
Conclusions
- * The 2024 OROV outbreak signifies a critical juncture, demanding increased attention.
- * There are significant gaps in understanding OROV pathogenesis.
- * There is an urgent need for the development of effective antivirals and vaccines against OROV.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Viral Recombination Can Create New Diseases
Some diseases can infect multiple species. For example, pigs can be infected by some human and...